Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex
暂无分享,去创建一个
[1] L. Lanier,et al. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. , 1997, Journal of immunology.
[2] K. Campbell,et al. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81 , 1997, The EMBO journal.
[3] H. Moriya,et al. A new 12-kilodalton dimer associated with pre-TCR complex and clonotype-independent CD3 complex on immature thymocytes. , 1997, Journal of immunology.
[4] P. Leibson. Signal transduction during natural killer cell activation: inside the mind of a killer. , 1997, Immunity.
[5] É. Vivier,et al. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. , 1997, Journal of immunology.
[6] L. Lanier,et al. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. , 1997, Journal of immunology.
[7] L. Lanier. Natural killer cells: from no receptors to too many. , 1997, Immunity.
[8] W. Seaman,et al. Mouse Ly-49A Interrupts Early Signaling Events in Natural Killer Cell Cytotoxicity and Functionally Associates with the SHP-1 Tyrosine Phosphatase , 1997, The Journal of experimental medicine.
[9] C. Biron. Activation and function of natural killer cell responses during viral infections. , 1997, Current opinion in immunology.
[10] T. George,et al. Role of murine NK cells and their receptors in hybrid resistance. , 1997, Current opinion in immunology.
[11] M. Llano,et al. Structure and function of the CD94 C‐type lectin receptor complex involved in recognition of HLA class I molecules , 1997, Immunological reviews.
[12] M. Colonna. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors , 1997, Immunological reviews.
[13] O. Mandelboim,et al. Enhancement of Class II-Restricted T cell Responses by Costimulatory NK Receptors for Class I MHC Proteins , 1996, Science.
[14] I. Melero,et al. Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. , 1996, Journal of immunology.
[15] J. Kinet,et al. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. , 1996, Immunity.
[16] S. Anderson,et al. The Ly-49D Receptor Activates Murine Natural Killer Cells , 1996, The Journal of experimental medicine.
[17] M. López-Botet,et al. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. , 1996, Journal of immunology.
[18] R. Biassoni,et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation , 1996, European journal of immunology.
[19] M. Colonna,et al. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C , 1996, The Journal of experimental medicine.
[20] L. Lanier,et al. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C , 1996, The Journal of experimental medicine.
[21] D. Marguet,et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. , 1996, Journal of immunology.
[22] M. Colonna,et al. A human killer inhibitory receptor specific for HLA-A1,2. , 1996, Journal of immunology.
[23] S. Sforzini,et al. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function. , 1996, Blood.
[24] J. Ritz,et al. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. , 1996, Experimental hematology.
[25] R. Biassoni,et al. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions , 1996, The Journal of experimental medicine.
[26] T. Mcclanahan,et al. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. , 1995, Journal of immunology.
[27] L. Moretta,et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.
[28] Eric O Long,et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.
[29] M. Colonna,et al. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.
[30] E. Palmer,et al. CART: a conserved antigen receptor transmembrane motif. , 1994, Seminars in immunology.
[31] G. Ferrara,et al. NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80 , 1994, The Journal of experimental medicine.
[32] E. Ciccone,et al. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 ζ chain, FcϵRI γ chain and the p56lck kinase , 1994 .
[33] M. Balboa,et al. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. , 1994, Journal of immunology.
[34] G. Ferrara,et al. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] P. Parham,et al. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type , 1993, The Journal of experimental medicine.
[36] J. O’Shea,et al. Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[37] N. Green. The semiotics of charge , 1991, Nature.
[38] J. Bonifacino,et al. Membrane protein association by potential intrarnembrane charge pairs , 1991, Nature.
[39] J. Shabanowitz,et al. Identification of the regulatory phosphorylation sites in pp42/mitogen‐activated protein kinase (MAP kinase). , 1991, The EMBO journal.
[40] K. S. Campbell,et al. B lymphocyte antigen receptors (mIg) are non‐covalently associated with a disulfide linked, inducibly phosphorylated glycoprotein complex. , 1990, The EMBO journal.
[41] Arthur Weiss,et al. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. , 1984, Journal of immunology.
[42] P. Parham,et al. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. , 1982, Journal of immunology.
[43] R. Biassoni,et al. Receptors for HLA class-I molecules in human natural killer cells. , 1996, Annual review of immunology.
[44] Eric O Long,et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.
[45] H. Ljunggren,et al. In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.
[46] E. Clark,et al. Human T Lymphocyte Cell Surface Molecules Defined by the Workshop Monoclonal Antibodies (“T Cell Protocol”) , 1984 .
[47] C. Heusser,et al. Induction of resting B cells to DNA synthesis by soluble monoclonal anti‐immunoglobulin , 1984, European journal of immunology.